Clinical Trial Update: Mono Efficacy of Capecitabine (MoniCa) [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the efficacy of capecitabine (MoniCa) in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Xeloda (capecitabine)

Snippet

Sponsor: GBG Forschungs GmbH | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED